The uptake of macronutrients by an active silicon accumulator plant growing in two different substrata

Pennisetum clandestinum (Graminae/Poaceae) an active Si-accumulator, was cultivated in two different substrata, both with reduced Si solubility. Plants growing in organic-rich soils contained much less Ca, K, Na and Si, than species growing in sandy soils. Although the highest macronutrient concentrations were associated to the highest Si levels in the organs of P. clandestinum, the R correlation values indicate that Si does not influence the internal balance and the uptake of these elements. In ca 65% of the cases roots have the highest average values regardless of the type of culture, while the contents of Mg in the shoots and roots of P. clandestinum were generally not significantly different (P>0.05). A significant decline of the macronutrient levels associated to the shoots and roots of P. clandestinum was observed from the 4th to the 6th month assay, especially for Ca in both organs, while for Mg and Na the decline is focused mainly in the shoots; K and Si decline is generally below 10%. When average values of Si in shoots and roots of plants collected from organic- rich and sandy soils were plotted against the average concentrations of Ca, K, Mg and Na in the same organs, weak but positive R correlation values were obtained - the highest R values were observed for Na and K and the lowest for Ca and Mg, regardless of the culture. Exception for the high R value observed for K, although the influence of Si on the K status in the whole plant is time-depending - R values, diminished from the 4th to the 6th month, as it happens in the majority of the cases. In conclusion, P. clandestinum can grow well and healthily in substrata with acid pH values and high carbonate content and low solubility of Si suggesting that the definition of the essentiality of Si, even in a Si-accumulator plant is still a matter of great controversy.publishersversionpublishe

Reduction of Inflammation and Colon Injury by a Spearmint Phenolic Extract in Experimental Bowel Disease in Mice

Background: Inflammatory Bowel Diseases (IBD) encompasses both Crohn’s Disease and Ulcerative Colitis, known to be connected to an enlarged risk for developing colorectal cancer (CRC). Spearmint (Mentha spicata L.) is a Mediterranean plant used as an aromatic agent, and studies have mainly focused on the essential oil suggesting an anti-inflammatory activity. This work aimed to perform a preliminary screening of the in vivo anti-inflammatory effects of a spearmint phenolic extract in an acute inflammation model, in a chronic inflammation model of colitis, and also study the effects in vitro on a colon cancer model. Methods: Spearmint extract was administered to rats of a paw oedema model (induced by carrageenan) and to mice from a TNBS-induced colitis model in parallel with studies using HT-29 CRC cells. Results: Administration of the extract led to reduced paw inflammation, reduction of colon injury and inflammation, with attenuation of histological markers, and reduction of iNOS expression. It repressed the in vitro movement of HT-29 cells in a wound healing assay. Conclusions: These findings suggest that spearmint extract exhibits acute and chronic anti-inflammatory activity and is able to inhibit migration of cancer cells, suggesting a potential role in the supplementary therapy of IBD patients.publishe

Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection

Mucosal vaccination appears to be suitable to protect against SARS-CoV-2 infection. In this study, we tested an intranasal mucosal vaccine candidate for COVID-19 that consisted of a cationic liposome containing a trimeric SARS-CoV-2 spike protein and CpG-ODNs, a Toll-like receptor 9 agonist, as an adjuvant. In vitro and in vivo experiments indicated the absence of toxicity following the intranasal administration of this vaccine formulation. First, we found that subcutaneous or intranasal vaccination protected hACE-2 transgenic mice from infection with the wild-type (Wuhan) SARS-CoV-2 strain, as shown by weight loss and mortality indicators. However, when compared with subcutaneous administration, the intranasal route was more effective in the pulmonary clearance of the virus and induced higher neutralizing antibodies and anti-S IgA titers. In addition, the intranasal vaccination afforded protection against gamma, delta, and omicron virus variants of concern. Furthermore, the intranasal vaccine formulation was superior to intramuscular vaccination with a recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 spike glycoprotein (Oxford/AstraZeneca) in terms of virus lung clearance and production of neutralizing antibodies in serum and bronchial alveolar lavage (BAL). Finally, the intranasal liposomal formulation boosted heterologous immunity induced by previous intramuscular vaccination with the Oxford/AstraZeneca vaccine, which was more robust than homologous immunity